Prothena Corp PLC (PRTA)
20.70
+0.13
(+0.63%)
USD |
NASDAQ |
Apr 19, 11:05
Prothena Cash from Financing (Quarterly): 0.483M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.483M |
| September 30, 2023 | 2.711M |
| June 30, 2023 | 18.62M |
| March 31, 2023 | 23.28M |
| December 31, 2022 | 220.76M |
| September 30, 2022 | 18.13M |
| June 30, 2022 | 1.225M |
| March 31, 2022 | 1.337M |
| December 31, 2021 | 1.773M |
| September 30, 2021 | 87.01M |
| June 30, 2021 | 20.22M |
| March 31, 2021 | 81.33M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.064M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.151M |
| December 31, 2019 | 0.013M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.21M |
| March 31, 2019 | 0.005M |
| December 31, 2018 | -1.304M |
| September 30, 2018 | -0.975M |
| June 30, 2018 | -0.861M |
| March 31, 2018 | 43.18M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.459M |
| September 30, 2017 | 2.608M |
| June 30, 2017 | 1.466M |
| March 31, 2017 | 159.87M |
| December 31, 2016 | 19.30M |
| September 30, 2016 | 4.242M |
| June 30, 2016 | 0.782M |
| March 31, 2016 | 128.96M |
| December 31, 2015 | -0.405M |
| September 30, 2015 | 2.656M |
| June 30, 2015 | 133.71M |
| March 31, 2015 | 1.026M |
| December 31, 2014 | -0.011M |
| September 30, 2014 | 14.67M |
| June 30, 2014 | 102.92M |
| March 31, 2014 | 0.507M |
| December 31, 2013 | 84.65M |
| September 30, 2013 | -0.117M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.084M |
| December 31, 2012 | 141.52M |
| September 30, 2012 | 7.552M |
| June 30, 2012 | 10.40M |
| March 31, 2012 | 8.761M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
220.76M
Maximum
Dec 2022
25.12M
Average
1.337M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| Amarin Corp PLC | 0.083M |
| Jazz Pharmaceuticals PLC | -100.31M |
| Iterum Therapeutics PLC | 0.589M |
| GH Research PLC | -0.041M |
| Mural Oncology PLC | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -51.04M |
| Cash from Investing (Quarterly) | -1.512M |
| Free Cash Flow | -136.72M |
| Free Cash Flow Per Share (Quarterly) | -0.9798 |
| Free Cash Flow to Equity (Quarterly) | -52.59M |
| Free Cash Flow to Firm (Quarterly) | -52.59M |
| Free Cash Flow Yield | -12.16% |